Intraventricular Hemorrhage: Clinical Trials

4 trials for Intraventricular Hemorrhage, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Terminated 1
Phase 21Terminated 1

Follow Intraventricular Hemorrhage: new trials by email Literature Review of Intraventricular Hemorrhage trials Research Report on Intraventricular Hemorrhage

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Start or STop Anticoagulants Randomised Trial (SoSTART)
Apixaban, Rivaroxaban, Edoxaban - Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive
Phase 3CompletedUniversity of Edinburgh2032018-03-282022-04-08
Clot Lysis: Evaluating Accelerated Resolution of Intraventricular Hemorrhage Phase III
Alteplase, Normal saline - Intraventricular Hemorrhage
Phase 3CompletedJohns Hopkins University5002009-07-012018-12-05
Inhaled Nitric Oxide and Neuroprotection in Premature Infants
inhaled nitric oxide, oxygen - Prematurity, Bronchopulmonary Dysplasia
Phase 2 / Phase 3TerminatedUniversity of Chicago2732008-05-012024-10-17
Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial)
magnesium sulfate - Cerebral Palsy, Intraventricular Hemorrhage
Phase 3CompletedThe George Washington University Biostatistics Center21361997-12-012019-07-12

Narrower conditions

Leukomalacia, Periventricular (2)  ·  Premature Birth (2)  ·  Abruptio Placentae (1)  ·  Atrial Fibrillation (1)  ·  Atrial Flutter (1)  ·  Bronchopulmonary Dysplasia (1)  ·  Cerebral Palsy (1)  ·  Cerebral Small Vessel Diseases (1)  ·  Hematoma, Subdural (1)  ·  Intracranial Hemorrhage, Hypertensive (1)  ·  Intracranial Hemorrhages (1)  ·  Pulmonary Edema (1)  ·  Subarachnoid Hemorrhage (1)

Broader conditions

Brain Diseases (3)  ·  Cardiovascular Diseases (3)  ·  Central Nervous System Diseases (3)  ·  Cerebrovascular Disorders (3)  ·  Nervous System Diseases (3)  ·  Vascular Diseases (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Encephalomalacia (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Infant, Newborn, Diseases (2)  ·  Infant, Premature, Diseases (2)  ·  Lung Diseases (2)  ·  Obstetric Labor Complications (2)  ·  Obstetric Labor, Premature (2)  ·  Pregnancy Complications (2)

Interventions

Acenocoumarol (1)  ·  Dabigatran (1)  ·  Magnesium Sulfate (1)  ·  Oxygen (1)  ·  Phenindione (1)  ·  Rivaroxaban (1)  ·  Saline Solution (1)  ·  Tissue Plasminogen Activator (1)  ·  Warfarin (1)  ·  apixaban (1)  ·  edoxaban (1)

Sponsors

Johns Hopkins University (1)  ·  The George Washington University Biostatistics Center (1)  ·  University of Chicago (1)  ·  University of Edinburgh (1)

Countries

United States (3)  ·  United Kingdom (2)  ·  Brazil (1)  ·  Canada (1)  ·  Germany (1)  ·  Hungary (1)  ·  Israel (1)  ·  Spain (1)  ·  Switzerland (1)

Top investigators

Daniel F. Hanley, MD (1)  ·  Dwight Rouse, MD (1)  ·  Menachem Miodovnik (1)  ·  Michael D. Schreiber, M.D. (1)  ·  Rustam Al-Shahi Salman, MA PhD FRCP (1)

Results publications

PMID 18753646, PMID 19622997, PMID 20027029, PMID 26243227, PMID 26254839, PMID 28081952, PMID 28887375, PMID 31143877, PMID 31177984, PMID 31571176, PMID 32026447, PMID 34022170, PMID 34487722, PMID 35086362, PMID 36700520

NIH funding

2016 (1), U01NS062851 (1), U10HD021410 (1), U10HD021414 (1), U10HD027860 (1), U10HD027861 (1), U10HD027869 (1), U10HD027905 (1), U10HD027915 (1), U10HD027917 (1), U10HD034116 (1), U10HD034122 (1), U10HD034136 (1), U10HD034208 (1), U10HD034210 (1)